These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25670890)

  • 1. A medical costs study of older patients with acute myocardial infarction and metabolic syndrome in hospital.
    Fan GQ; Fu KL; Jin CW; Wang XZ; Han L; Wang H; Zhong M; Zhang Y; Zhang W; Wang ZH
    Clin Interv Aging; 2015; 10():329-37. PubMed ID: 25670890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of metabolic syndrome and hypertension on medical costs of patients with acute myocardial infarction at hospital.
    Fan GQ; Fu KL; Song M; Han L; Jin CW; Zhong M; Zhang Y; Zhang W; Wang ZH
    Clin Exp Hypertens; 2015; 37(8):627-32. PubMed ID: 26114352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents.
    Won KB; Kim BK; Chang HJ; Shin DH; Kim JS; Ko YG; Choi D; Ha JW; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):713-20. PubMed ID: 23934969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan.
    Liao CT; Hsieh TH; Shih CY; Liu PY; Wang JD
    Sci Rep; 2021 Mar; 11(1):5608. PubMed ID: 33692425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of type 2 diabetes mellitus on hospitalization costs in older patients with acute myocardial infarction.
    Fu KL; Fan GQ; Han L; Wang XZ; Wang J; Wang YS; Zhong M; Zhang Y; Zhang W; Wang ZH
    Clin Interv Aging; 2014; 9():711-8. PubMed ID: 24812498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011.
    Sugiyama T; Hasegawa K; Kobayashi Y; Takahashi O; Fukui T; Tsugawa Y
    J Am Heart Assoc; 2015 Mar; 4(3):e001445. PubMed ID: 25801759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.
    Clavijo LC; Pinto TL; Kuchulakanti PK; Torguson R; Chu WW; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2006; 7(1):7-11. PubMed ID: 16513517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.
    Bakhai A; Stone GW; Grines CL; Murphy SA; Githiora L; Berezin RH; Cox DA; Stuckey T; Griffin JJ; Tcheng JE; Cohen DJ;
    Circulation; 2003 Dec; 108(23):2857-63. PubMed ID: 14610016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction.
    Nakatani D; Sakata Y; Sato H; Mizuno H; Shimizu M; Suna S; Ito H; Koretsune Y; Hirayama A; Hori M;
    Am J Cardiol; 2007 Apr; 99(7):885-9. PubMed ID: 17398177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: analysis of the Korean Acute Myocardial Infarction Registry.
    Yamanaka F; Jeong MH; Saito S; Ahn Y; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Cho JG; Seung KB; Park SJ;
    J Cardiol; 2013 Oct; 62(4):210-6. PubMed ID: 23731919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Metabolic Syndrome on Outcomes in Patients Aged <50 Years Versus >50 Years With Acute Myocardial Infarction.
    Kim I; Kim MC; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Seung KB; Chang K; Ahn Y
    Am J Cardiol; 2018 Jul; 122(2):192-198. PubMed ID: 29729896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of drug-eluting stents in acute myocardial infarction patients in Germany: results from administrative data using a propensity score-matching approach.
    Bäumler M; Stargardt T; Schreyögg J; Busse R
    Appl Health Econ Health Policy; 2012 Jul; 10(4):235-48. PubMed ID: 22574616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
    Iyanoye A; Moreyra AE; Swerdel JN; Gandhi SK; Cabrera J; Cosgrove NM; Kostis JB;
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):221-8. PubMed ID: 25645156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Liang JJ; Fender EA; Cha YM; Lennon RJ; Prasad A; Barsness GW
    Am J Cardiol; 2016 Mar; 117(5):709-13. PubMed ID: 26796195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and in-hospital outcome of acute ST segment elevation myocardial infarction in young Bangladeshi adults.
    Karim MA; Majumder AA; Islam KQ; Alam MB; Paul ML; Islam MS; Chowdhury KN; Islam SM
    BMC Cardiovasc Disord; 2015 Jul; 15():73. PubMed ID: 26197888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction.
    Zeller M; Steg PG; Ravisy J; Laurent Y; Janin-Manificat L; L'Huillier I; Beer JC; Oudot A; Rioufol G; Makki H; Farnier M; Rochette L; Vergès B; Cottin Y;
    Arch Intern Med; 2005 May; 165(10):1192-8. PubMed ID: 15911735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: the Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study.
    Machecourt J; Bonnefoy E; Vanzetto G; Motreff P; Marlière S; Leizorovicz A; Allenet B; Lacroute JM; Cassagnes J; Touboul P
    J Am Coll Cardiol; 2005 Feb; 45(4):515-24. PubMed ID: 15708697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating cost-effectiveness evidence into clinical practice guidelines in Australia for acute myocardial infarction.
    Antioch KM; Jennings G; Botti M; Chapman R; Wulfsohn V
    Eur J Health Econ; 2002; 3(1):26-39. PubMed ID: 15609115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.